The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,951.00
Ask: 1,953.00
Change: -1.00 (-0.05%)
Spread: 2.00 (0.103%)
Open: 1,942.00
High: 1,958.00
Low: 1,938.00
Prev. Close: 1,959.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Equities Firm Ahead Of Central Bank Meetings

Thu, 05th Sep 2013 09:56

LONDON (Alliance News) - London's main equity markets all trade modestly higher by mid morning Thursday with the FTSE 100 up just 0.2% at 6,488 points. The FTSE 250 is 0.5% higher, while the AIM All-Share is 0.1% higher.

European markets opened with positivity taken from Asia, where markets have closed higher after the Bank of Japan revised up its assessment of the economy but kept liquidity high, with its monetary easing program unchanged. The FTSE 100, CAC 40 and DAX all opened strongly, each rising about 0.5% but have slid slightly by mid morning with the European majors now about flat on the day.

Traders seem less concerned this morning by the ongoing debate over military intervention in Syria over its alleged use of chemical weapons. US President Barack Obama secured backing from a Senate committee late on Wednesday for a limited strike on the country, but will now have to get through a full House and Senate vote which will wait until next week.

Following Wednesday's profit warning from Ryanair that sent all airline stocks tumbling, most are rebounding strongly Thursday after the release of August traffic statistics from easyJet that showed an increase in passenger numbers of 3.9% over the month. EasyJet shares trade 1.56% higher, and International Consolidated Airlines Group trade 2% higher.

At the other end of the spectrum, pharmaceuticals are amongst the biggest fallers as GSK released disappointing results of tests of a new melanoma treatment drug. GSK is one of the biggest blue-chip fallers, down 1.5%. Hikma is down 0.9% and Shire down 0.3%.

Another positive economic reading for the UK has come in the form of new car sales, which have increased for the 18th month in a row and are now above pre-recession levels. The data is helping the pound to maintain Wednesday's break above 1.56 against the dollar, currently trading at USD1.5615.

Big events still to come are central bank meetings.

The BoE's decisions on interest rates and asset purchasing are due at mid-day. No change is expected, and there is no mandatory statement. With every economic indicator of late coming out strongly, Governor Mark Carney may prefer to remain quiet Thursday. However if any statement is released it will be watched with keen interest as to how Carney will further defend his forward guidance.

Also, at 1245 BST, the ECB will announce interest rates. Again, no change expected but Governor Mario Draghi will be giving his usual press conference.

By Jon Darby; jondarby@alliancenews.com; @jondarby100

Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.